RISW2026
Back to all people

Qing Xu

2 appearances in the program

Sessions & presentations

PS05: Advancing Biomarker-Driven Intermediate Endpoints in Oncology: Current Status and Future Directions
Parallel · Thu, Sep 17 , 1:15 PM
Organizer
PS05: Advancing Biomarker-Driven Intermediate Endpoints in Oncology: Current Status and Future Directions
Presentation: An Industry Perspective on Biomarker Validation: Balancing Scientific Rigor and Practical Utility for Intermediate Endpoints
Parallel · Thu, Sep 17 , 1:15 PM
Presenting Author
↑